Teachers Advisors LLC decreased its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 11.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 344,298 shares of the medical equipment provider’s stock after selling 43,419 shares during the period. Teachers Advisors LLC owned about 0.17% of Zimmer Biomet Holdings worth $44,208,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Parkside Financial Bank & Trust increased its holdings in shares of Zimmer Biomet Holdings by 2.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after purchasing an additional 22 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Zimmer Biomet Holdings by 25.3% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 167 shares in the last quarter. Parallel Advisors LLC increased its holdings in shares of Zimmer Biomet Holdings by 20.8% in the 1st quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock worth $138,000 after purchasing an additional 199 shares in the last quarter. IHT Wealth Management LLC increased its holdings in shares of Zimmer Biomet Holdings by 28.4% in the 1st quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 256 shares in the last quarter. Finally, Sandy Spring Bank increased its holdings in shares of Zimmer Biomet Holdings by 1.7% in the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after purchasing an additional 20 shares in the last quarter. 85.35% of the stock is owned by institutional investors and hedge funds.

Several analysts recently commented on ZBH shares. Zacks Investment Research lowered Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Wells Fargo & Company reaffirmed a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Morgan Stanley lifted their price objective on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $125.00 price objective on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. Zimmer Biomet Holdings has a consensus rating of “Hold” and an average target price of $136.75.

In other news, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.07% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: “Zimmer Biomet Holdings, Inc. (ZBH) Shares Sold by Teachers Advisors LLC” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/09/18/zimmer-biomet-holdings-inc-zbh-shares-sold-by-teachers-advisors-llc.html.

Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at 115.47 on Monday. The stock has a market capitalization of $23.35 billion, a P/E ratio of 32.89 and a beta of 1.21. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49. The stock has a 50 day moving average price of $114.88 and a 200 day moving average price of $120.74.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.10 by ($0.02). The company had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. Zimmer Biomet Holdings’s revenue for the quarter was up 1.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.02 earnings per share. Equities analysts predict that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 27.59%.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.